Alnylam Pharmaceuticals, Inc. (ALNY)
Today's Latest Price: $125.66 USD
Updated Nov 24 6:55pm
Add ALNY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
Alnylam Pharmaceuticals Inc (ALNY) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ALNY.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 23 | $225 | $90 | $163.43 | $123.02 | 32.85% |
ALNY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.35 | 15 | 1 | 8 | 0 | 0 | 24 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Alnylam Pharmaceuticals Inc's percent of analysts bearish on the stock is less than nearly 100% of all US stocks.
- ALNY has a greater number of analysts covering the stock than 98.78% of Pharmaceutical Products stocks.
- Alnylam Pharmaceuticals Inc's average analyst price target is greater than 95.63% of Pharmaceutical Products stocks.
- The upside potential (average analyst target price relative to current price) of ALNY is higher than 90.9% of stocks in the large market cap category.
- The variance in analysts' estimates of ALNY is lower than 9.28% of all US stocks.
- ALNY has a higher percentage of analysts bullish on the stock than 28.24% of Pharmaceutical Products stocks.
- ALNY has a less change in bullishness amongst analysts than nearly 100% of all US stocks.
Stocks similar to Alnylam Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NBIX, BMRN and SAGE.
Is ALNY a Buy, Hold or Sell? See the POWR Ratings now!
